ConductScience.org, home

Trial · NCT02279641

Results by group58

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Maximum Observed Plasma Concentration (Cmax)Allopurinol: Allopurinol Alone1.1395% Confidence Interval 0.894 to 1.43μg/mL
Maximum Observed Plasma Concentration (Cmax)Allopurinol: RDEA3170 + Allopurinol1.5195% Confidence Interval 1.24 to 1.82μg/mL
Maximum Observed Plasma Concentration (Cmax)Oxypurinol: Allopurinol Alone12.895% Confidence Interval 11.7 to 14.0μg/mL
Maximum Observed Plasma Concentration (Cmax)Oxypurinol: RDEA3170 + Allopurinol8.6895% Confidence Interval 7.99 to 9.43μg/mL
Time of Occurrence of Maximum Observed Concentration (Tmax)Allopurinol: Allopurinol Alone1.50Full Range 1.00 to 4.00hr
Time of Occurrence of Maximum Observed Concentration (Tmax)Allopurinol: RDEA3170 + Allopurinol1.25Full Range 0.500 to 4.00hr
Time of Occurrence of Maximum Observed Concentration (Tmax)Oxypurinol: Allopurinol Alone4.00Full Range 1.50 to 6.00hr
Time of Occurrence of Maximum Observed Concentration (Tmax)Oxypurinol: RDEA3170 + Allopurinol3.50Full Range 1.50 to 8.00hr
Time of Occurrence of Maximum Observed Concentration (Tmax)RDEA3170: RDEA3170 Alone3.00Full Range 1.50 to 4.00hr
Time of Occurrence of Maximum Observed Concentration (Tmax)RDEA3170: RDEA3170 + Allopurinol3.00Full Range 2.00 to 10.0hr
Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24)Allopurinol: Allopurinol Alone3.6995% Confidence Interval 3.24 to 4.21μg·hr/mL
Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24)Allopurinol: RDEA3170 + Allopurinol3.6895% Confidence Interval 3.28 to 4.13μg·hr/mL
Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24)Oxypurinol: Allopurinol Alone25595% Confidence Interval 229 to 284μg·hr/mL
Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24)Oxypurinol: RDEA3170 + Allopurinol15795% Confidence Interval 140 to 177μg·hr/mL
Area Under the Concentration-time Curve From Time Zero up to 24 Hours Postdose (AUC 0-24)RDEA3170: RDEA3170 + Allopurinol11595% Confidence Interval 96.5 to 137μg·hr/mL
Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last)Allopurinol: Allopurinol Alone3.5095% Confidence Interval 3.04 to 4.04μg·hr/mL
Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last)Allopurinol: RDEA3170 + Allopurinol3.6195% Confidence Interval 3.22 to 4.05μg·hr/mL
Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last)Oxypurinol: Allopurinol Alone25595% Confidence Interval 229 to 284μg·hr/mL
Area Under the Concentration-time Curve From Time Zero to the Last Quantifiable Sampling Timepoint (AUC Last)Oxypurinol: RDEA3170 + Allopurinol15795% Confidence Interval 140 to 177μg·hr/mL
Apparent Terminal Half-life (t1/2)Allopurinol: Allopurinol Alone1.0695% Confidence Interval 0.969 to 1.15hr

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02279641/results